Table 2. Clinical and technical findings at index presentation.
| Diabetes | No diabetes | p-value | |
|---|---|---|---|
| n, (%) | 1489 (36.3) | 2612 (63.7) | |
| In-patient stay, % (n) | 76.2 (1135) | 68.6 (1792) | <0.001 |
| Outpatient clinic, % (n) | 23.8 (354) | 31.4 (820) | <0.001 |
| BMI (kg/m2) ‡ | 28.4 | 26.2 | <0.001 |
| Systolic blood pressure—mmHg ‡ | 120 (110;140) | 120 (110;135) | <0.001 |
| Diastolic blood pressure—mmHg ‡ | 70 (64;80) | 70 (65;80) | 0.39 |
| NYHA functional class: | <0.001 | ||
| NYHA class I—% (n/total n) | 7.5 (111/1488) | 13.0 (340/2606) | |
| NYHA class II—% (n/total n) | 31.3 (465/1488) | 33.1 (863/2606) | |
| NYHA class III—% (n/total n) | 46.4 (690/1488) | 40.3 (1051/2606) | |
| NYHA class IV—% (n/total n) | 14.9 (222/1488) | 13.5 (352/2606) | |
| LVEF—% ‡ | 30 (23;35) | 30 (23;35) | 0.71 |
| LVEF ≤ 30%—% (n/total n) | 62.8 (935/1489) | 60.7 (1586/2612) | 0.19 |
| Quality of life—MLWHFQ Score ‡* | 40 (25;57) | 32 (17;50) | <0.001 |
‡ median (quartiles), BMI body mass index, NYHA New York Heart Association, LVEF left ventricular ejection fraction,
* documented in 36% of patients only due to later introduction in June 2011.